RNXT

RenovoRx (RNXT)

About RenovoRx (RNXT)

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Mountain View, CA.

Details

Daily high

$1.01

Daily low

$0.97

Price at open

$0.98

52 Week High

$1.69

52 Week Low

$0.77

Market cap

35.3M

Dividend yield

0.00%

Volume

34,275

Avg. volume

64,435

P/E ratio

-1.73

RenovoRx News